Political scientists have, for years, assumed leaders matter because they represent interest groups. Personalities and other individual traits are often seen as much less important. But what happens when someone with an inflated ego or little experience becomes the one in control? A group of political scientists at the University of California San Diego are expanding the conversation.
More than 100 physicians from UC San Diego Health were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 45 diverse specialties, from infectious disease, surgery and oncology to obstetrics, cardiology and emergency medicine.
From self-folding robots, to robotic endoscopes, to better methods for computer vision and object detection, researchers at the University of California San Diego have a wide range of papers and workshop presentations at the International Conference on Intelligent Robots and Systems (or IROS) which takes place from Sept. 24 to 28 in Vancouver, Canada. UC San Diego researchers also are organizing workshops on a range of themes during the event.
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now. In a paper, University of California San Diego School of Medicine researchers identified exosomes — extremely small vesicles or sacs secreted from most cell types — as the missing link.
Scientists have found that ignored pieces of DNA play a critical role in the development of immune cells called T cells. These areas activate a change in the 3D structure of DNA that brings together crucial elements necessary for T cell formation. This “big bang” discovery may be unfolding throughout the animal and plant kingdoms as well as aid in combating diseases such as lymphoma and leukemia.
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers may have found a way to double down on immunotherapy’s effectiveness.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
